| Title |
Randomized Placebo-Controlled Trial Evaluating the Ophthalmic Safety of Single-Dose Tafenoquine in Healthy Volunteers
|
|---|---|
| Published in |
Drug Safety, June 2019
|
| DOI | 10.1007/s40264-019-00839-w |
| Pubmed ID | |
| Authors |
Jessica Ackert, Khadeeja Mohamed, Jason S. Slakter, Sherif El-Harazi, Alessandro Berni, Hakop Gevorkyan, Elizabeth Hardaker, Azra Hussaini, Siôn W. Jones, Gavin C. K. W. Koh, Jyoti Patel, Scott Rasmussen, Deborah S. Kelly, David E. Barañano, John T. Thompson, Keith A. Warren, Robert C. Sergott, John Tonkyn, Allen Wolstenholme, Hanna Coleman, Alex Yuan, Stephan Duparc, Justin A. Green |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Sweden | 1 | 33% |
| United States | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Scientists | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 38 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 6 | 16% |
| Student > Doctoral Student | 5 | 13% |
| Student > Ph. D. Student | 5 | 13% |
| Other | 3 | 8% |
| Student > Bachelor | 3 | 8% |
| Other | 6 | 16% |
| Unknown | 10 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 16 | 42% |
| Biochemistry, Genetics and Molecular Biology | 3 | 8% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Immunology and Microbiology | 1 | 3% |
| Nursing and Health Professions | 1 | 3% |
| Other | 2 | 5% |
| Unknown | 13 | 34% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 August 2019.
All research outputs
#15,575,425
of 23,150,406 outputs
Outputs from Drug Safety
#1,409
of 1,709 outputs
Outputs of similar age
#217,391
of 353,595 outputs
Outputs of similar age from Drug Safety
#19
of 27 outputs
Altmetric has tracked 23,150,406 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,709 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one is in the 11th percentile – i.e., 11% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,595 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 22nd percentile – i.e., 22% of its contemporaries scored the same or lower than it.